Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| HCST | Q9UBK5 | Hematopoietic cell signal transducer (DNAX-activation protein 10) (Membrane protein DAP10) (Transmembrane adapter protein KAP10) | Predicted membrane proteins | 1 | Immune mediationReceptor-signaling mediation | 5 | 0.53 | |||
| HEG1 | Q9ULI3 | Protein HEG homolog 1 | Plasma proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 5 | 0.53 | |||
| ICOS | Q9Y6W8 | Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278) | CD markersDisease related genesHuman disease related genes | 1 | Lupus erythematosusSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 5 | 0.53 | ||
| ICOSL | O75144 | ICOS ligand (B7 homolog 2) (B7-H2) (B7-like protein Gl50) (B7-related protein 1) (B7RP-1) (CD antigen CD275) | CD markersPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | |||
| IGDC4 | Q8TDY8 | Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36) | Plasma proteinsPredicted membrane proteins | 1 | Other mediation | 5 | 0.53 | |||
| ITA5 | P08648 | Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain] | Cancer-related genesCD markersPlasma proteins | 1 | Allergic/hypersensitivity disorderAsthmaMultiple sclerosis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | ||
| KCJ15 | Q99712 | ATP-sensitive inward rectifier potassium channel 15 (Inward rectifier K(+) channel Kir1.3) (Inward rectifier K(+) channel Kir4.2) (Potassium channel, inwardly rectifying subfamily J member 15) | FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins | 2 | Clinical-translation mediationFusion and delivery mediation | 5 | 0.53 | |||
| KCNN3 | Q9UGI6 | Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Myelopathy | Clinical-translation mediationFusion and delivery mediation | 5 | 0.53 | ||
| KELL | P23276 | Kell blood group glycoprotein (EC 3.4.24.-) (CD antigen CD238) | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 5 | 0.53 | ||||
| NKG2D | P26718 | NKG2-D type II integral membrane protein (Killer cell lectin-like receptor subfamily K member 1) (NK cell receptor D) (NKG2-D-activating NK receptor) (CD antigen CD314) | Cancer-related genesCD markersPredicted membrane proteins | 1 | Acute myeloid leukaemiaColorectal cancerCrohn disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 |